Literature DB >> 30774558

Radiosensitizing properties of magnetic hyperthermia mediated by superparamagnetic iron oxide nanoparticles (SPIONs) on human cutaneous melanoma cell lines.

Jakub Dalibor Rybka1.   

Abstract

Melanoma is responsible for the majority of deaths related to skin cancer. Worryingly, prognoses show an increasing number of melanoma cases each year worldwide. Radiotherapy, which is a cornerstone of cancer treatment, has proved to be useful but insufficient in melanoma management due to exceptionally high radioresistance of melanoma cells. This problem could be overcome by superparamagnetic iron oxide nanoparticles (SPIONs) used as heat mediators in magnetic hyperthermia, which not only enhance radiosensitivity, but also enable precise targeting by exploitation of their magnetic properties.

Entities:  

Keywords:  Melanoma; Radiosensitization; Superparamagnetic iron oxide nanoparticles

Year:  2019        PMID: 30774558      PMCID: PMC6365839          DOI: 10.1016/j.rpor.2019.01.002

Source DB:  PubMed          Journal:  Rep Pract Oncol Radiother        ISSN: 1507-1367


  56 in total

Review 1.  Mechanisms of therapy-related carcinogenesis.

Authors:  James M Allan; Lois B Travis
Journal:  Nat Rev Cancer       Date:  2005-12       Impact factor: 60.716

2.  OH radicals and oxidizing products in the gamma radiolysis of water.

Authors:  J A LaVerne
Journal:  Radiat Res       Date:  2000-02       Impact factor: 2.841

3.  Locally advanced melanoma: results of postoperative hypofractionated radiation therapy.

Authors:  G Stevens; J F Thompson; I Firth; C J O'Brien; W H McCarthy; M J Quinn
Journal:  Cancer       Date:  2000-01-01       Impact factor: 6.860

4.  The use of gold nanoparticles to enhance radiotherapy in mice.

Authors:  James F Hainfeld; Daniel N Slatkin; Henry M Smilowitz
Journal:  Phys Med Biol       Date:  2004-09-21       Impact factor: 3.609

5.  Development of functionalized superparamagnetic iron oxide nanoparticles for interaction with human cancer cells.

Authors:  A Petri-Fink; M Chastellain; L Juillerat-Jeanneret; A Ferrari; H Hofmann
Journal:  Biomaterials       Date:  2005-05       Impact factor: 12.479

Review 6.  Cellular and molecular biology of human melanoma.

Authors:  K Satyamoorthy; M Herlyn
Journal:  Cancer Biol Ther       Date:  2002 Jan-Feb       Impact factor: 4.742

7.  Surface modified superparamagnetic nanoparticles for drug delivery: interaction studies with human fibroblasts in culture.

Authors:  Ajay Kumar Gupta; Adam S G Curtis
Journal:  J Mater Sci Mater Med       Date:  2004-04       Impact factor: 3.896

8.  Hepatic cellular distribution and degradation of iron oxide nanoparticles following single intravenous injection in rats: implications for magnetic resonance imaging.

Authors:  Karen Briley-Saebo; Atle Bjørnerud; Derek Grant; Håkan Ahlstrom; Trond Berg; Grete Mørk Kindberg
Journal:  Cell Tissue Res       Date:  2004-04-23       Impact factor: 5.249

9.  Increased metastatic dissemination in human melanoma xenografts after subcurative radiation treatment: radiation-induced increase in fraction of hypoxic cells and hypoxia-induced up-regulation of urokinase-type plasminogen activator receptor.

Authors:  Einar K Rofstad; Berit Mathiesen; Kanthi Galappathi
Journal:  Cancer Res       Date:  2004-01-01       Impact factor: 12.701

Review 10.  Estimation of an optimal radiotherapy utilization rate for gastrointestinal carcinoma: a review of the evidence.

Authors:  Geoff Delaney; Michael Barton; Susannah Jacob
Journal:  Cancer       Date:  2004-08-15       Impact factor: 6.860

View more
  8 in total

1.  Bioinformatics analysis based on ferroptosis-related lncRNAs: construction of a clinical prognostic model for nasopharyngeal carcinoma and correlation analysis.

Authors:  Zuwen Dai; Yi Zhong
Journal:  Transl Cancer Res       Date:  2022-06       Impact factor: 0.496

2.  Emerging medical applications based on non-ionizing electromagnetic fields from 0 Hz to 10 THz.

Authors:  Mats-Olof Mattsson; Myrtill Simkó
Journal:  Med Devices (Auckl)       Date:  2019-09-12

3.  Multifunctional Nanoparticles Based on Iron Oxide and Gold-198 Designed for Magnetic Hyperthermia and Radionuclide Therapy as a Potential Tool for Combined HER2-Positive Cancer Treatment.

Authors:  Michał Żuk; Rafał Podgórski; Anna Ruszczyńska; Tomasz Ciach; Agnieszka Majkowska-Pilip; Aleksander Bilewicz; Paweł Krysiński
Journal:  Pharmaceutics       Date:  2022-08-12       Impact factor: 6.525

4.  The Influence of Synthesis Parameters on Structural and Magnetic Properties of Iron Oxide Nanomaterials.

Authors:  Laura Madalina Cursaru; Roxana Mioara Piticescu; Dumitru Valentin Dragut; Ioan Albert Tudor; Victor Kuncser; Nicusor Iacob; Florentin Stoiciu
Journal:  Nanomaterials (Basel)       Date:  2020-01-02       Impact factor: 5.076

Review 5.  Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy.

Authors:  Xiaoli Liu; Yifan Zhang; Yanyun Wang; Wenjing Zhu; Galong Li; Xiaowei Ma; Yihan Zhang; Shizhu Chen; Shivani Tiwari; Kejian Shi; Shouwen Zhang; Hai Ming Fan; Yong Xiang Zhao; Xing-Jie Liang
Journal:  Theranostics       Date:  2020-02-19       Impact factor: 11.556

6.  Impact of superparamagnetic iron oxide nanoparticles on in vitro and in vivo radiosensitisation of cancer cells.

Authors:  Emily Russell; Victoria Dunne; Ben Russell; Hibaaq Mohamud; Mihaela Ghita; Stephen J McMahon; Karl T Butterworth; Giuseppe Schettino; Conor K McGarry; Kevin M Prise
Journal:  Radiat Oncol       Date:  2021-06-12       Impact factor: 3.481

7.  Low Blue Dose Photodynamic Therapy with Porphyrin-Iron Oxide Nanoparticles Complexes: In Vitro Study on Human Melanoma Cells.

Authors:  Simona Nistorescu; Ana-Maria Udrea; Madalina Andreea Badea; Iulia Lungu; Mihai Boni; Tatiana Tozar; Florian Dumitrache; Valentin-Adrian Maraloiu; Roua Gabriela Popescu; Claudiu Fleaca; Ecaterina Andronescu; Anca Dinischiotu; Angela Staicu; Mihaela Balas
Journal:  Pharmaceutics       Date:  2021-12-10       Impact factor: 6.321

Review 8.  Surface-functionalised hybrid nanoparticles for targeted treatment of cancer.

Authors:  Hasnat Tariq; Syed Ali Imran Bokhari
Journal:  IET Nanobiotechnol       Date:  2020-09       Impact factor: 1.847

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.